ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALDX Aldeyra Therapeutics Inc

4.12
0.19 (4.83%)
Last Updated: 00:13:39
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aldeyra Therapeutics Inc ALDX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.19 4.83% 4.12 00:13:39
Open Price Low Price High Price Close Price Previous Close
3.93 3.8901 4.18 3.93
more quote information »

Recent News

Date Time Source Heading
18/4/202421:00BWAldeyra Therapeutics to Host Research & Development Day on..
28/3/202422:00BWAldeyra Therapeutics Announces Clinical Development Plan for..
08/3/202408:54EDGAR2Form S-3 - Registration statement under Securities Act of..
08/3/202408:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202408:40EDGAR2Form S-8 POS - Securities to be offered to employees in..
08/3/202408:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202423:00BWAldeyra Therapeutics to Participate in the Oppenheimer 34th..
30/1/202409:25EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202423:00EDGAR2Form 8-K - Current report
04/1/202423:00BWAldeyra Therapeutics Provides Clinical and Regulatory Update..
22/12/202308:06EDGAR2Form 8-K - Current report
19/12/202323:05EDGAR2Form 8-K - Current report
19/12/202323:00BWAldeyra Therapeutics Announces Statistically and Clinically..
19/12/202308:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
28/11/202323:16EDGAR2Form 8-K - Current report
28/11/202308:07BWAldeyra Therapeutics Receives Complete Response Letter from..
04/11/202307:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202307:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202322:09EDGAR2Form 8-K - Current report
01/11/202322:05BWAldeyra Therapeutics Enters into Exclusive Option Agreement..
16/10/202323:00EDGAR2Form 8-K - Current report
27/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25/8/202306:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/8/202319:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
09/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04/8/202319:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
04/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/7/202321:00BWAldeyra Therapeutics to Participate in SVB Securities..
06/7/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202307:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/7/202306:07EDGAR2Form 8-K - Current report
30/6/202306:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202321:01EDGAR2Form 8-K - Current report
29/6/202321:00BWAldeyra Therapeutics Announces Improvement from Baseline in..
29/6/202306:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
27/6/202321:00BWAldeyra Therapeutics Announces Statistically Significant..
27/6/202306:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
23/6/202321:00BWAldeyra Therapeutics to Join the Russell 2000® and Russell..
21/6/202323:34BWAldeyra Therapeutics Provides Regulatory Update on ADX-2191
15/6/202321:00BWAldeyra Therapeutics Announces Achievement of Statistical..
15/6/202306:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
02/6/202321:00BWAldeyra Therapeutics to Participate in Fireside Chat at the..

Your Recent History

Delayed Upgrade Clock